BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36522845)

  • 1. Clinical history of female-to-male transgender patients is needed to avoid misinterpretation of cervical Papanicolaou tests.
    Moatamed NA; Barco AD; Yang SE; Ying Y; Zhang S; Rodriguez EF
    Cytopathology; 2023 Mar; 34(2):120-129. PubMed ID: 36522845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomorphologic findings of cervical Pap smears from female-to-male transgender patients on testosterone therapy.
    Williams MPA; Kukkar V; Stemmer MN; Khurana KK
    Cancer Cytopathol; 2020 Jul; 128(7):491-498. PubMed ID: 32125771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
    Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
    Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
    Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
    J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone.
    Lin LH; Zhou F; Elishaev E; Khader S; Hernandez A; Marcus A; Adler E
    Diagn Cytopathol; 2022 Nov; 50(11):518-524. PubMed ID: 36181432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Cervical Cancer Screen Results on Female-to-Male Transgender Patients With Female Patients.
    Davis K; Kwon R; Graham A; White M; Maleki Z; Rodriguez E
    Am J Clin Pathol; 2022 Apr; 157(4):540-545. PubMed ID: 34617991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
    Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
    Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
    Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Doxtader EE; Brainard JA; Underwood D; Chute DJ
    Cancer Cytopathol; 2017 Jan; 125(1):60-69. PubMed ID: 27731938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and secondary prevention of cervical cancer among Italian AFAB transgender people.
    Lami A; Alvisi S; Siconolfi A; Seracchioli R; Meriggiola MC
    Curr Probl Cancer; 2024 Jun; 50():101103. PubMed ID: 38744064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.
    Peitzmeier SM; Reisner SL; Harigopal P; Potter J
    J Gen Intern Med; 2014 May; 29(5):778-84. PubMed ID: 24424775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
    Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.